ID   CDHR2_HUMAN             Reviewed;        1310 AA.
AC   Q9BYE9; A1L3U4; A6NC80; Q9NXP8;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=Cadherin-related family member 2 {ECO:0000305};
DE   AltName: Full=Protocadherin LKC {ECO:0000303|PubMed:12117771};
DE            Short=PC-LKC {ECO:0000303|PubMed:12117771};
DE   AltName: Full=Protocadherin-24 {ECO:0000303|PubMed:24725409};
DE   Flags: Precursor;
GN   Name=CDHR2 {ECO:0000312|HGNC:HGNC:18231};
GN   Synonyms=PCDH24 {ECO:0000303|PubMed:24725409}, PCLKC
GN   {ECO:0000303|PubMed:12117771};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAB40777.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, TOPOLOGY, INTERACTION WITH MAST2, AND VARIANTS ALA-424 AND
RP   MET-1128.
RC   TISSUE=Kidney {ECO:0000312|EMBL:BAB40777.1};
RX   PubMed=12117771; DOI=10.1093/carcin/23.7.1139;
RA   Okazaki N., Takahashi N., Kojima S., Masuho Y., Koga H.;
RT   "Protocadherin LKC, a new candidate for a tumor suppressor of colon and
RT   liver cancers, its association with contact inhibition of cell
RT   proliferation.";
RL   Carcinogenesis 23:1139-1148(2002).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAA90962.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-424; MET-1128 AND
RP   MET-1164.
RC   TISSUE=Colon {ECO:0000312|EMBL:BAA90962.1}, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-424 AND MET-1128.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=15534908; DOI=10.3748/wjg.v10.i24.3569;
RA   Yang L.Y., Wang W., Peng J.X., Yang J.Q., Huang G.W.;
RT   "Differentially expressed genes between solitary large hepatocellular
RT   carcinoma and nodular hepatocellular carcinoma.";
RL   World J. Gastroenterol. 10:3569-3573(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, DOMAIN, INTERACTION WITH MYO7B
RP   AND USH1C, MUTAGENESIS OF LEU-1310, REGION, AND TISSUE SPECIFICITY.
RX   PubMed=24725409; DOI=10.1016/j.cell.2014.01.067;
RA   Crawley S.W., Shifrin D.A. Jr., Grega-Larson N.E., McConnell R.E.,
RA   Benesh A.E., Mao S., Zheng Y., Zheng Q.Y., Nam K.T., Millis B.A.,
RA   Kachar B., Tyska M.J.;
RT   "Intestinal brush border assembly driven by protocadherin-based
RT   intermicrovillar adhesion.";
RL   Cell 157:433-446(2014).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1248, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   INTERACTION WITH USH1C.
RX   PubMed=26812017; DOI=10.1016/j.devcel.2015.12.020;
RA   Li J., He Y., Lu Q., Zhang M.;
RT   "Mechanistic basis of organization of the Harmonin/USH1C-mediated brush
RT   border microvilli tip-link complex.";
RL   Dev. Cell 36:179-189(2016).
RN   [9]
RP   IDENTIFICATION OF THE IMAC COMPLEX.
RX   PubMed=26812018; DOI=10.1016/j.devcel.2015.12.022;
RA   Crawley S.W., Weck M.L., Grega-Larson N.E., Shifrin D.A. Jr., Tyska M.J.;
RT   "ANKS4B is essential for intermicrovillar adhesion complex formation.";
RL   Dev. Cell 36:190-200(2016).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-1004.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Intermicrovillar adhesion molecule that forms, via its
CC       extracellular domain, calcium-dependent heterophilic complexes with
CC       CDHR5 on adjacent microvilli. Thereby, controls the packing of
CC       microvilli at the apical membrane of epithelial cells. Through its
CC       cytoplasmic domain, interacts with microvillus cytoplasmic proteins to
CC       form the intermicrovillar adhesion complex/IMAC. This complex plays a
CC       central role in microvilli and epithelial brush border differentiation
CC       (PubMed:24725409). May also play a role in cell-cell adhesion and
CC       contact inhibition in epithelial cells (PubMed:12117771).
CC       {ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:24725409}.
CC   -!- SUBUNIT: Part of the IMAC/intermicrovillar adhesion
CC       complex/intermicrovillar tip-link complex composed of ANKS4B, MYO7B,
CC       USH1C, CDHR2 and CDHR5 (PubMed:26812018). Interacts with MAST2
CC       (PubMed:12117771). Interacts (via cytoplasmic domain) with USH1C and
CC       MYO7B; required for proper localization of CDHR2 to microvilli tips and
CC       its function in brush border differentiation (PubMed:24725409,
CC       PubMed:26812017). {ECO:0000269|PubMed:12117771,
CC       ECO:0000269|PubMed:24725409, ECO:0000269|PubMed:26812017,
CC       ECO:0000269|PubMed:26812018}.
CC   -!- INTERACTION:
CC       Q9BYE9; Q9HBB8-1: CDHR5; NbExp=3; IntAct=EBI-493793, EBI-9540729;
CC       Q9BYE9; Q9HBB8-2: CDHR5; NbExp=3; IntAct=EBI-493793, EBI-9629917;
CC       Q9BYE9; Q6P0Q8: MAST2; NbExp=4; IntAct=EBI-493793, EBI-493777;
CC       Q9BYE9; Q6PIF6: MYO7B; NbExp=3; IntAct=EBI-493793, EBI-4400912;
CC       Q9BYE9; Q9Y6N9-1: USH1C; NbExp=2; IntAct=EBI-493793, EBI-9541226;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:24725409}; Single-pass
CC       type I membrane protein {ECO:0000269|PubMed:12117771,
CC       ECO:0000269|PubMed:24725409}. Cell projection, microvillus membrane
CC       {ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:24725409}; Single-pass
CC       type I membrane protein {ECO:0000269|PubMed:12117771,
CC       ECO:0000269|PubMed:24725409}. Cell junction
CC       {ECO:0000269|PubMed:12117771}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, kidney and colon.
CC       Moderately expressed in small intestine. Down-regulated in a number of
CC       liver and colon cancers (PubMed:12117771, PubMed:15534908). Expressed
CC       in duodenum with higher expression in enterocytes along the villus axis
CC       and lower expression in crypts (at protein level) (PubMed:24725409).
CC       {ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:15534908,
CC       ECO:0000269|PubMed:24725409}.
CC   -!- DOMAIN: The cadherin 1 domain is required for binding to CDHR5.
CC       {ECO:0000269|PubMed:24725409}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA90962.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=A tighter mesh - Issue 178
CC       of April 2016;
CC       URL="https://web.expasy.org/spotlight/back_issues/178/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB047004; BAB40777.1; -; mRNA.
DR   EMBL; AK000131; BAA90962.1; ALT_INIT; mRNA.
DR   EMBL; AK315055; BAG37531.1; -; mRNA.
DR   EMBL; AC091934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC130282; AAI30283.1; -; mRNA.
DR   CCDS; CCDS34297.1; -.
DR   RefSeq; NP_001165447.1; NM_001171976.1.
DR   RefSeq; NP_060145.3; NM_017675.4.
DR   PDB; 5CZR; X-ray; 2.30 A; A/B/C/D=21-237.
DR   PDB; 7N86; X-ray; 3.17 A; A/B/C/D=21-240.
DR   PDBsum; 5CZR; -.
DR   PDBsum; 7N86; -.
DR   AlphaFoldDB; Q9BYE9; -.
DR   SMR; Q9BYE9; -.
DR   BioGRID; 120179; 14.
DR   IntAct; Q9BYE9; 8.
DR   STRING; 9606.ENSP00000424565; -.
DR   MoonDB; Q9BYE9; Predicted.
DR   GlyConnect; 1922; 4 N-Linked glycans (2 sites).
DR   GlyCosmos; Q9BYE9; 24 sites, 4 glycans.
DR   GlyGen; Q9BYE9; 24 sites, 4 N-linked glycans (2 sites).
DR   iPTMnet; Q9BYE9; -.
DR   PhosphoSitePlus; Q9BYE9; -.
DR   BioMuta; CDHR2; -.
DR   DMDM; 209572658; -.
DR   jPOST; Q9BYE9; -.
DR   MassIVE; Q9BYE9; -.
DR   MaxQB; Q9BYE9; -.
DR   PaxDb; Q9BYE9; -.
DR   PeptideAtlas; Q9BYE9; -.
DR   ProteomicsDB; 79633; -.
DR   Antibodypedia; 2236; 51 antibodies from 11 providers.
DR   DNASU; 54825; -.
DR   Ensembl; ENST00000261944.10; ENSP00000261944.5; ENSG00000074276.11.
DR   Ensembl; ENST00000510636.5; ENSP00000424565.1; ENSG00000074276.11.
DR   GeneID; 54825; -.
DR   KEGG; hsa:54825; -.
DR   MANE-Select; ENST00000261944.10; ENSP00000261944.5; NM_017675.6; NP_060145.3.
DR   UCSC; uc003mem.3; human.
DR   AGR; HGNC:18231; -.
DR   CTD; 54825; -.
DR   DisGeNET; 54825; -.
DR   GeneCards; CDHR2; -.
DR   HGNC; HGNC:18231; CDHR2.
DR   HPA; ENSG00000074276; Tissue enriched (intestine).
DR   MIM; 619713; gene.
DR   neXtProt; NX_Q9BYE9; -.
DR   OpenTargets; ENSG00000074276; -.
DR   PharmGKB; PA165660231; -.
DR   VEuPathDB; HostDB:ENSG00000074276; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   GeneTree; ENSGT00940000161160; -.
DR   HOGENOM; CLU_005755_0_0_1; -.
DR   InParanoid; Q9BYE9; -.
DR   OMA; DYEECDQ; -.
DR   OrthoDB; 5350857at2759; -.
DR   PhylomeDB; Q9BYE9; -.
DR   TreeFam; TF332908; -.
DR   PathwayCommons; Q9BYE9; -.
DR   SignaLink; Q9BYE9; -.
DR   BioGRID-ORCS; 54825; 10 hits in 1143 CRISPR screens.
DR   ChiTaRS; CDHR2; human.
DR   GeneWiki; PCLKC; -.
DR   GenomeRNAi; 54825; -.
DR   Pharos; Q9BYE9; Tbio.
DR   PRO; PR:Q9BYE9; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9BYE9; protein.
DR   Bgee; ENSG00000074276; Expressed in jejunal mucosa and 131 other tissues.
DR   ExpressionAtlas; Q9BYE9; baseline and differential.
DR   Genevisible; Q9BYE9; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IDA:UniProtKB.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IDA:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0090675; P:intermicrovillar adhesion; IMP:UniProtKB.
DR   GO; GO:0060243; P:negative regulation of cell growth involved in contact inhibition; IDA:UniProtKB.
DR   GO; GO:0032532; P:regulation of microvillus length; IMP:UniProtKB.
DR   CDD; cd11304; Cadherin_repeat; 9.
DR   Gene3D; 2.60.40.60; Cadherins; 9.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   PANTHER; PTHR24027:SF422; CADHERIN DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR24027; CADHERIN-23; 1.
DR   Pfam; PF00028; Cadherin; 7.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 9.
DR   SUPFAM; SSF49313; Cadherin-like; 9.
DR   PROSITE; PS00232; CADHERIN_1; 7.
DR   PROSITE; PS50268; CADHERIN_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Cell junction; Cell membrane;
KW   Cell projection; Differentiation; Glycoprotein; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..1310
FT                   /note="Cadherin-related family member 2"
FT                   /id="PRO_0000004011"
FT   TOPO_DOM        21..1154
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1155..1175
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1176..1310
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..124
FT                   /note="Cadherin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          125..241
FT                   /note="Cadherin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          242..353
FT                   /note="Cadherin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          368..480
FT                   /note="Cadherin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          481..586
FT                   /note="Cadherin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          586..695
FT                   /note="Cadherin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          696..808
FT                   /note="Cadherin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          810..928
FT                   /note="Cadherin 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          930..1058
FT                   /note="Cadherin 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   REGION          1180..1310
FT                   /note="Mediates interaction with USH1C and MYO7B and is
FT                   required for proper localization to microvilli tips and
FT                   function in microvilli organization"
FT                   /evidence="ECO:0000269|PubMed:24725409"
FT   REGION          1259..1310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1259..1273
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1294..1310
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1248
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q7P9"
FT   CARBOHYD        29
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        371
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        401
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        460
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        565
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        600
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        616
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        632
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        680
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        696
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        701
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        775
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        821
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        871
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        877
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        911
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        932
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1107
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         107
FT                   /note="Q -> H (in dbSNP:rs6886860)"
FT                   /id="VAR_046695"
FT   VARIANT         415
FT                   /note="A -> G (in dbSNP:rs3762960)"
FT                   /id="VAR_046696"
FT   VARIANT         424
FT                   /note="V -> A (in dbSNP:rs11134982)"
FT                   /evidence="ECO:0000269|PubMed:12117771,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046697"
FT   VARIANT         766
FT                   /note="L -> P (in dbSNP:rs752138)"
FT                   /id="VAR_046698"
FT   VARIANT         901
FT                   /note="T -> M (in dbSNP:rs35018750)"
FT                   /id="VAR_046699"
FT   VARIANT         948
FT                   /note="V -> M (in dbSNP:rs3749625)"
FT                   /id="VAR_046700"
FT   VARIANT         1004
FT                   /note="P -> L (found in an acute myeloid leukemia sample;
FT                   somatic mutation; dbSNP:rs371676123)"
FT                   /evidence="ECO:0000269|PubMed:18987736"
FT                   /id="VAR_054148"
FT   VARIANT         1128
FT                   /note="T -> M (in dbSNP:rs2291442)"
FT                   /evidence="ECO:0000269|PubMed:12117771,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046701"
FT   VARIANT         1164
FT                   /note="L -> M (in dbSNP:rs17078347)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_021548"
FT   MUTAGEN         1310
FT                   /note="L->R: Loss of interaction with USH1C."
FT                   /evidence="ECO:0000269|PubMed:24725409"
FT   CONFLICT        64
FT                   /note="G -> S (in Ref. 1; BAB40777)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1229
FT                   /note="D -> G (in Ref. 2; BAA90962)"
FT                   /evidence="ECO:0000305"
FT   HELIX           28..31
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          32..36
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          43..47
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          59..64
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          70..72
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          78..81
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   TURN            87..89
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          91..100
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          105..115
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:7N86"
FT   STRAND          130..134
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          142..145
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   HELIX           154..157
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          159..168
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   HELIX           173..175
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   TURN            193..196
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          198..208
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:5CZR"
FT   STRAND          225..232
FT                   /evidence="ECO:0007829|PDB:5CZR"
SQ   SEQUENCE   1310 AA;  141543 MW;  E0BC8AEEF8D9E1F2 CRC64;
     MAQLWLSCFL LPALVVSVAA NVAPKFLANM TSVILPEDLP VGAQAFWLVA EDQDNDPLTY
     GMSGPNAYFF AVTPKTGEVK LASALDYETL YTFKVTISVS DPYIQVQREM LVIVEDRNDN
     APVFQNTAFS TSINETLPVG SVVFSVLAVD KDMGSAGMVV YSIEKVIPST GDSEHLFRIL
     ANGSIVLNGS LSYNNKSAFY QLELKACDLG GMYHNTFTIQ CSLPVFLSIS VVDQPDLDPQ
     FVREFYSASV AEDAAKGTSV LTVEAVDGDK GINDPVIYSI SYSTRPGWFD IGADGVIRVN
     GSLDREQLLE ADEEVQLQVT ATETHLNIYG QEAKVSIWVT VRVMDVNDHK PEFYNCSLPA
     CTFTPEEAQV NFTGYVDEHA SPRIPIDDLT MVVYDPDKGS NGTFLLSLGG PDAEAFSVSP
     ERAVGSASVQ VLVRVSALVD YERQTAMAVQ VVATDSVSQN FSVAMVTIHL RDINDHRPTF
     PQSLYVLTVP EHSATGSVVT DSIHATDPDT GAWGQITYSL LPGNGADLFQ VDPVSGTVTV
     RNGELLDRES QAVYYLTLQA TDGGNLSSST TLQIHLLDIN DNAPVVSGSY NIFVQEEEGN
     VSVTIQAHDN DEPGTNNSRL LFNLLPGPYS HNFSLDPDTG LLRNLGPLDR EAIDPALEGR
     IVLTVLVSDC GEPVLGTKVN VTITVEDIND NLPIFNQSSY NFTVKEEDPG VLVGVVKAWD
     ADQTEANNRI SFSLSGSGAN YFMIRGLVLG AGWAEGYLRL PPDVSLDYET QPVFNLTVSA
     ENPDPQGGET IVDVCVNVKD VNDNPPTLDV ASLRGIRVAE NGSQHGQVAV VVASDVDTSA
     QLEIQLVNIL CTKAGVDVGS LCWGWFSVAA NGSVYINQSK AIDYEACDLV TLVVRACDLA
     TDPGFQAYSN NGSLLITIED VNDNAPYFLP ENKTFVIIPE LVLPNREVAS VRARDDDSGN
     NGVILFSILR VDFISKDGAT IPFQGVFSIF TSSEADVFAG SIQPVTSLDS TLQGTYQVTV
     QARDRPSLGP FLEATTTLNL FTVDQSYRSR LQFSTPKEEV GANRQAINAA LTQATRTTVY
     IVDIQDIDSA ARARPHSYLD AYFVFPNGSA LTLDELSVMI RNDQDSLTQL LQLGLVVLGS
     QESQESDLSK QLISVIIGLG VALLLVLVIM TMAFVCVRKS YNRKLQAMKA AKEARKTAAG
     VMPSAPAIPG TNMYNTERAN PMLNLPNKDL GLEYLSPSND LDSVSVNSLD DNSVDVDKNS
     QEIKEHRPPH TPPEPDPEPL SVVLLGRQAG ASGQLEGPSY TNAGLDTTDL
//
